Vanguard Capital Wealth Advisors Takes Position in Nike Inc (NKE)

Share on StockTwits

Vanguard Capital Wealth Advisors acquired a new position in shares of Nike Inc (NYSE:NKE) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,250 shares of the footwear maker’s stock, valued at approximately $275,000.

A number of other large investors have also recently bought and sold shares of the business. Handelsbanken Fonder AB raised its stake in shares of Nike by 21.2% in the first quarter. Handelsbanken Fonder AB now owns 273,000 shares of the footwear maker’s stock valued at $18,138,000 after acquiring an additional 47,800 shares during the period. WINTON GROUP Ltd raised its stake in shares of Nike by 3.9% in the first quarter. WINTON GROUP Ltd now owns 101,615 shares of the footwear maker’s stock valued at $6,751,000 after acquiring an additional 3,803 shares during the period. Summit Trail Advisors LLC raised its stake in shares of Nike by 6,331.7% in the first quarter. Summit Trail Advisors LLC now owns 672,760 shares of the footwear maker’s stock valued at $673,000 after acquiring an additional 662,300 shares during the period. Suntrust Banks Inc. grew its holdings in shares of Nike by 27.6% in the first quarter. Suntrust Banks Inc. now owns 255,750 shares of the footwear maker’s stock worth $16,991,000 after purchasing an additional 55,347 shares during the last quarter. Finally, 180 Wealth Advisors LLC bought a new position in shares of Nike in the first quarter worth about $202,000. 64.35% of the stock is currently owned by hedge funds and other institutional investors.

In other Nike news, EVP Monique S. Matheson sold 17,000 shares of Nike stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $83.15, for a total transaction of $1,413,550.00. Following the sale, the executive vice president now owns 104,737 shares of the company’s stock, valued at approximately $8,708,881.55. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Johnathan A. Rodgers sold 16,000 shares of Nike stock in a transaction on Wednesday, September 19th. The stock was sold at an average price of $85.05, for a total transaction of $1,360,800.00. Following the sale, the director now directly owns 26,963 shares in the company, valued at approximately $2,293,203.15. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 50,000 shares of company stock worth $4,219,350. 3.90% of the stock is currently owned by corporate insiders.

Nike stock traded down $1.42 during trading on Friday, reaching $76.36. The company had a trading volume of 4,737,581 shares, compared to its average volume of 7,704,791. Nike Inc has a 1-year low of $55.08 and a 1-year high of $86.04. The stock has a market capitalization of $123.52 billion, a P/E ratio of 31.55, a P/E/G ratio of 2.43 and a beta of 0.77. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.53 and a current ratio of 2.31.

Nike (NYSE:NKE) last released its quarterly earnings results on Tuesday, September 25th. The footwear maker reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.04. Nike had a net margin of 5.57% and a return on equity of 40.69%. The firm had revenue of $9.95 billion for the quarter, compared to analysts’ expectations of $9.92 billion. During the same quarter last year, the company earned $0.57 EPS. The firm’s revenue for the quarter was up 9.7% compared to the same quarter last year. Sell-side analysts predict that Nike Inc will post 2.62 EPS for the current year.

NKE has been the topic of a number of research analyst reports. HSBC set a $92.00 price target on shares of Nike and gave the stock a “buy” rating in a report on Thursday, September 6th. Robert W. Baird restated a “buy” rating and issued a $90.00 price target on shares of Nike in a report on Monday, September 3rd. Macquarie set a $87.00 price target on shares of Nike and gave the stock a “buy” rating in a report on Tuesday, August 28th. Stifel Nicolaus restated a “buy” rating and issued a $90.00 price target on shares of Nike in a report on Thursday, August 23rd. Finally, Morgan Stanley restated a “buy” rating and issued a $88.00 price target on shares of Nike in a report on Friday, August 10th. Two analysts have rated the stock with a sell rating, fifteen have issued a hold rating and twenty-four have given a buy rating to the company’s stock. Nike has a consensus rating of “Buy” and a consensus target price of $85.63.

COPYRIGHT VIOLATION WARNING: This story was reported by BBNS and is the sole property of of BBNS. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://baseballnewssource.com/2018/11/12/vanguard-capital-wealth-advisors-invests-275000-in-nike-inc-nke-stock/2854369.html.

About Nike

NIKE, Inc, together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide. The company offers NIKE brand products in six categories: running, NIKE basketball, the Jordan brand, football, training, and sportswear. It also markets products designed for kids, as well as for other athletic and recreational uses, such as American football, baseball, cricket, lacrosse, skateboarding, tennis, volleyball, wrestling, walking, and outdoor activities; and apparel with licensed college and professional team and league logos, as well as sells sports apparel.

Read More: What is dollar cost averaging (DCA)?

Institutional Ownership by Quarter for Nike (NYSE:NKE)

Receive News & Ratings for Nike Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nike and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.